Skip to main content
NCD 160.23 · version 2

NCD 160.23: Sensory Nerve Conduction Threshold Tests (sNCTs)

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 160.23

Benefit category
Diagnostic X-Ray Tests
Effective date
04/01/2004
Implemented 04/01/2004
Transmittal
Transmittal 15
Versions published
2
Manual section
160
Nervous System, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 160.23 sets Medicare's national policy for sensory nerve conduction threshold tests (sncts) under the benefit category "Diagnostic X-Ray Tests", effective 04/01/2004 and implemented 04/01/2004. All uses of sNCT to diagnose sensory neuropathies or radiculopathies are noncovered. It has been revised 1 time since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

A. General

The sNCT is a psychophysical assessment of both central and peripheral nerve functions. It measures the detection threshold of accurately calibrated sensory stimuli. This procedure is intended to evaluate and quantify function in both large and small caliber fibers for the purpose of detecting neurologic disease. Sensory perception and threshold detection are dependent on the integrity of both the peripheral sensory apparatus and peripheral-central sensory pathways. In theory, an abnormality detected by this procedure may signal dysfunction anywhere in the sensory pathway from the receptors, the sensory tracts, the primary sensory cortex, to the association cortex.

This procedure is different and distinct from assessment of nerve conduction velocity, amplitude and latency. It is also different from short-latency somatosensory evoked potentials.

Effective October 1, 2002, CMS initially concluded that there was insufficient scientific or clinical evidence to consider the sNCT test and the device used in performing this test reasonable and necessary within the meaning of section 1862(a)(1)(A) of the law. Therefore, sNCT was noncovered.

Effective April 1, 2004, based on a reconsideration of current Medicare policy for sNCT, CMS concludes that the use of any type of sNCT device (e.g., “current output” type device used to perform current perception threshold (CPT), pain perception threshold (PPT), or pain tolerance threshold (PTT) testing or “voltage input” type device used for voltage-nerve conduction threshold (v-NCT) testing) to diagnose sensory neuropathies or radiculopathies in Medicare beneficiaries is not reasonable and necessary.

Indications and limitations of coverage

B. Nationally Covered Indications

Not applicable.

C. Nationally Noncovered Indications

All uses of sNCT to diagnose sensory neuropathies or radiculopathies are noncovered.

(This NCD last reviewed June 2004.)

Text reproduced from the CMS Medicare Coverage Database record for NCD 160.23 version 2. View the original on cms.gov.

Local policies that build on this NCD

8 active Local Coverage Determinations cite NCD 160.23 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

  • Nerve Conduction Studies and Electromyography (L34594) · Wisconsin Physicians Service Insurance Corporation
  • LCD L34624: Somatosensory Testing · Wisconsin Physicians Service Insurance Corporation
  • L34433 Somatosensory Testing · Palmetto GBA
  • L34859 Nerve Conduction Studies and Electromyography · First Coast Service Options, Inc.
  • L35081 Nerve Conduction Studies and Electromyography · Novitas Solutions, Inc.
  • L35098 Nerve Conduction Studies and Electromyography · Wellpoint Federal
  • L35906 Somatosensory Testing · CGS Administrators, LLC
  • L36524 Nerve Conduction Studies and Electromyography · Noridian Healthcare Solutions, LLC

How MACs bill NCD 160.23

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 8 current articles in the Medicare Coverage Database name NCD 160.23, 8 of them with a covered ICD-10-CM list, from 6 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

A54095: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2025-10-01 · Novitas Solutions, Inc. (04111, 04112, 04211, 04212, 04311, 04312, 04411, 04412, 04911, 07101, 07102, 07201, 07202, 07301, 07302, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12501, 12502, 12901) · CMS record

1,372 covered ICD-10-CM codes in 6 groups; 33 procedure codes: 0106T, 0107T, 0108T, 0109T, 0110T, 51784, 51785, 92265, 95860, 95861, 95863, 95864 and 21 more. Local policy: L35081 Nerve Conduction Studies and Electromyography. Check a diagnosis for 0106T.

First covered codes: E08.43 Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy; E09.43 Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy; E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy; E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy; E13.43 Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy; G20.A1 Parkinson's disease without dyskinesia, without mention of fluctuations; …

A54969: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2026-10-01 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record

1,517 covered ICD-10-CM codes; 30 procedure codes: 51785, 92265, 95860, 95861, 95863, 95864, 95865, 95866, 95867, 95868, 95869, 95870 and 18 more. Local policy: L36524 Nerve Conduction Studies and Electromyography. Check a diagnosis for 51785.

First covered codes: A05.1 Botulism food poisoning; A35 Other tetanus; A52.15 Late syphilitic neuropathy; B91 Sequelae of poliomyelitis; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; …

A57041: Billing and Coding: Somatosensory Testing

Billing and Coding, effective 2026-03-26 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

556 covered ICD-10-CM codes; 4 procedure codes: 95925, 95926, 95927, 95938. Local policy: L35906 Somatosensory Testing. Check a diagnosis for 95925.

First covered codes: A18.01 Tuberculosis of spine; C41.2 Malignant neoplasm of vertebral column; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; C72.0 Malignant neoplasm of spinal cord; C72.1 Malignant neoplasm of cauda equina; …

A57123: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2025-10-01 · First Coast Service Options, Inc. (09101, 09102, 09201, 09202, 09302) · CMS record

1,372 covered ICD-10-CM codes in 6 groups; 33 procedure codes: 0106T, 0107T, 0108T, 0109T, 0110T, 51784, 51785, 92265, 95860, 95861, 95863, 95864 and 21 more. Local policy: L34859 Nerve Conduction Studies and Electromyography. Check a diagnosis for 0106T.

First covered codes: E08.43 Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy; E09.43 Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy; E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy; E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy; E13.43 Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy; G20.A1 Parkinson's disease without dyskinesia, without mention of fluctuations; …

A57307: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2026-05-07 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

1,126 covered ICD-10-CM codes; 31 procedure codes: 51784, 51785, 92265, 95860, 95861, 95863, 95864, 95865, 95866, 95867, 95868, 95869 and 19 more. Local policy: L35897 Nerve Conduction Studies and Electromyography. Check a diagnosis for 51784.

First covered codes: A05.1 Botulism food poisoning; A35 Other tetanus; A52.15 Late syphilitic neuropathy; B91 Sequelae of poliomyelitis; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; …

A57478: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2026-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

1,163 covered ICD-10-CM codes; 30 procedure codes: 51785, 92265, 95860, 95861, 95863, 95864, 95865, 95866, 95867, 95868, 95869, 95870 and 18 more. Local policy: L34594 Nerve Conduction Studies and Electromyography. Check a diagnosis for 51785.

First covered codes: A05.1 Botulism food poisoning; A35 Other tetanus; A52.15 Late syphilitic neuropathy; B91 Sequelae of poliomyelitis; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; …

A57597: Billing and Coding: Somatosensory Testing

Billing and Coding, effective 2025-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

656 covered ICD-10-CM codes in 3 groups; 4 procedure codes: 95925, 95926, 95927, 95938. Local policy: L34624 Somatosensory Testing. Check a diagnosis for 95925.

First covered codes: A18.01 Tuberculosis of spine; C41.2 Malignant neoplasm of vertebral column; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; C72.0 Malignant neoplasm of spinal cord; C72.1 Malignant neoplasm of cauda equina; …

A57668: Billing and Coding: Nerve Conduction Studies and Electromyography

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

1,629 covered ICD-10-CM codes in 2 groups; 30 procedure codes: 51785, 92265, 95860, 95861, 95863, 95864, 95865, 95866, 95867, 95868, 95869, 95870 and 18 more. Local policy: L35098 Nerve Conduction Studies and Electromyography. Check a diagnosis for 51785.

First covered codes: A35 Other tetanus; A52.15 Late syphilitic neuropathy; B91 Sequelae of poliomyelitis; C70.0 Malignant neoplasm of cerebral meninges; C70.1 Malignant neoplasm of spinal meninges; C70.9 Malignant neoplasm of meninges, unspecified; …

Coverage analysis history

CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links 2 analyses to NCD 160.23, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.

  1. CAG-00106N Electrodiagnostic Sensory Nerve Conduction Threshold (New, Closed)
  2. CAG-00106R Electrodiagnostic Sensory Nerve Conduction Threshold (1st Recon, Closed)

Revision history

06/2004 - Reaffirmed existing Medicare noncoverage policy on any type of Sensory Nerve Conduction Threshold (sNCT) Test, and device used to perform test, to diagnose sensory neuropathies or radiculopathies. Recinds and replaces TN 8. Effective and implementation dates 04/01/2004. ( TN 15 ) (CR 3339)

03/2004 - Reaffired existing Medicare noncoverage policy on Current Perception Threshold/Sensory Nerve Conduction Threshold Test (sNCT). Effective and implementation dates 04/01/2004. ( TN 8 ) (CR 2988)

05/2002 - Provided that there is insufficient scientific or clinical evidence to consider this device as reasonable and necessary within the meaning of §1862(a)(1)(A) of the Social Security Act and will not be covered by Medicare. Also, established a new code G0255 for this test. The code descriptor is Current Perception Threshold/Sensory Nerve Conduction Threshold test (sNCT), per limb, any nerve - (Not covered by Medicare). Effective and implementation dates 07/01/2002. ( TN 156 ) (CR 2153)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 160.23

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 160.23

What does NCD 160.23 cover?

All uses of sNCT to diagnose sensory neuropathies or radiculopathies are noncovered. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 160.23 take effect?

The current version (2) is effective 04/01/2004, implemented 04/01/2004, published in transmittal 15. CMS lists 2 versions of this NCD.

Does a Local Coverage Determination override NCD 160.23?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.